Skip to main content

Table 2 Clinical factor screening information sheet

From: A novel prognostic prediction model based on seven immune-related RNAs for predicting overall survival of patients in early cervical squamous cell carcinoma

Clinical characteristics

TCGA (N = 181)

Uni-variables cox

Multi-variables cox

HR

95%CI

P

HR

95%CI

P

Age (years, mean ± sd)

47.06 ± 13.83

1.005

0.981–1.029

6.93E−01

–

–

–

Neoplasm histologic grade (G1/G2/G3/–)

11/77/77/16

1.219

0.655–2.269

5.30E−01

–

–

–

Pathologic M (M0/M1/–)

79/3/99

11.060

1.130- 108.2

9.48E−03

5.960

0.598–59.39

1.28E−01

Pathologic N (N0/N1/–)

97/30/54

3.410

1.541–7.547

1.33E−03

3.238

1.468–7.142

3.61E−03

Pathologic T (T1/T2/–)

99/50/32

1.263

0.584–2.729

5.52E−01

–

–

–

Pathologic stage (I/II)

123/58

0.820

0.396–1.696

5.87E−01

–

–

–

Number of pregnancies (0/1/2/3/over 3/–)

10/18/30/28/75/20

1.028

0.794–1.333

8.31E−01

–

–

–

Radio-therapy (yes/no/–)

105/53/23

1.190

0.571–2.479

6.42E−01

–

–

–

RS model status (high/low)

90/91

3.485

1.717–7.076

2.35E−04

2.518

1.122–5.651

2.51E−02

Vital status (dead/alive)

38/143

–

–

–

–

–

–

Overall survival time (months, mean ± sd)

37.83 ± 40.02

–

–

–

–

–

–

  1. HR, hazard ratio; CI, confidence interval; N, number